APA (7th ed.) Citation

S, M., H, S., & K, K. (2026). Modified monitoring of abiraterone acetate-induced hepatotoxicity in prostate cancer patients. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 32(3), 466. https://doi.org/10.1177/10781552241291515

Chicago Style (17th ed.) Citation

S, Mishra, Spencer H, and Kelly K. "Modified Monitoring of Abiraterone Acetate-induced Hepatotoxicity in Prostate Cancer Patients." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners 32, no. 3 (2026): 466. https://doi.org/10.1177/10781552241291515.

MLA (9th ed.) Citation

S, Mishra, et al. "Modified Monitoring of Abiraterone Acetate-induced Hepatotoxicity in Prostate Cancer Patients." Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, vol. 32, no. 3, 2026, p. 466, https://doi.org/10.1177/10781552241291515.